USPTO Examiner LAUER CHRISTINA C - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19241649VACUUM ASSISTED OCCLUSION OF THE LEFT ATRIAL APPENDAGEJune 2025December 2025Allow620YesNo
18962737DEVICE TO RESTRAIN OPENING OF AN OFF-THE-SHELF SURGICAL INSTRUMENTNovember 2024February 2025Allow300NoNo
18776051Systems and Methods for Customizable Flow Diverter ImplantsJuly 2024November 2024Allow400NoNo
18769695SYSTEMS, DEVICES, AND METHODS FOR ENDOSCOPE OR LAPAROSCOPE MAGNETIC NAVIGATIONJuly 2024December 2025Allow1700YesNo
18760322Intrasaccular Aneurysm Occlusion Device with a Convex Distal Portion Nested within a Concave Proximal PortionJuly 2024June 2025Abandon1140NoNo
18674996Globular Mesh Compressed into Multilayer Bowl-Shaped Aneurysm Neck BridgeMay 2024December 2024Abandon720NoNo
18661707SURGICAL ROBOT ARMMay 2024December 2025Allow1931YesNo
18654455ARTERIOTOMY CLOSURE APPARATUS WITH SLOTTED SHOE FOR ADVANTAGEOUS PRESSURE DISTRIBUTIONMay 2024March 2025Allow1110NoNo
18644279END-TO-END CONNECTOR FOR TEXTILE GRAFT ANASTOMOSISApril 2024July 2025Abandon1520NoNo
18620677HEMOSTASIS RELOADABLE CLIPPING DEVICE WITH SLEEVE ENGAGEMENTMarch 2024June 2025Allow1510NoNo
18613053Systems and Methods for Forming and Deploying the Janjua Aneurysm Net plus Bridge (JAN-B) for Cerebral Aneurysm OcclusionMarch 2024October 2024Abandon720NoYes
18683672SURGICAL INSTRUMENT SHEARSFebruary 2024January 2026Allow2300NoNo
18406561MEDICAL CATHETERJanuary 2024November 2024Allow1010NoNo
18528599DIFFUSION AND INFUSION RESISTANT IMPLANTABLE DEVICES FOR REDUCING PULSATILE PRESSUREDecember 2023January 2025Abandon1410NoNo
18519055Methods for Creating an Expandable Two-Part Intrasacular Aneurysm Occlusion Device from a Tubular MeshNovember 2023April 2024Allow500YesNo
18511410SUTURE ANCHOR FOR KNOTLESS FIXATION OF TISSUENovember 2023November 2024Allow1210NoNo
18507833TWO BALLOON CATHETER METHODS FOR ASPIRATION AND CONTROLLED DELIVERY OF CLOSURE AGENTSNovember 2023August 2024Allow920NoNo
18389117VARIABLE DENIER YARN AND SUTURENovember 2023January 2025Allow1500NoNo
18489473LEFT ATRIAL APPENDAGE CLOSURE IMPLANTOctober 2023March 2026Allow2930NoNo
18485128EMBOLIC DEVICES FOR OCCLUDING BODY LUMENSOctober 2023July 2024Allow1010NoNo
18374602Janjua Aneurysm Net and Other Intrasacular Aneurysm Occlusion DevicesSeptember 2023January 2024Allow421NoNo
18369779DELIVERY CATHETER SYSTEMS AND METHODSSeptember 2023January 2025Allow1611NoNo
18460867ANASTOMOSIS DEVICESeptember 2023December 2025Allow2710NoNo
18241535SYSTEMS, DEVICES, AND METHODS FOR ENDOSCOPE OR LAPAROSCOPE MAGNETIC NAVIGATIONSeptember 2023March 2024Allow700YesNo
18236674Systems and Methods for Customizable Flow Diverter ImplantsAugust 2023July 2025Allow2300NoNo
18236194SYSTEMS, DEVICES, AND METHODS FOR FORMING ANASTOMOSESAugust 2023June 2025Allow2230YesNo
18448792SYSTEMS AND METHODS FOR DETERMINING FAILURE OF INTRAGASTRIC DEVICESAugust 2023June 2025Abandon2320NoNo
18231298LOADING APPARATUS AND SYSTEM FOR EXPANDABLE INTRALUMINAL MEDICAL DEVICESAugust 2023September 2025Allow2540YesNo
18328501METHODS AND DEVICES TO REDUCE DAMAGING EFFECTS OF CONCUSSIVE OR BLAST FORCES ON A SUBJECTJune 2023December 2024Allow1820NoNo
18328356METHOD FOR TREATING SCALP ARTERIOVENOUS FISTULA USING MICRO VASCULAR PLUGJune 2023January 2026Allow3210YesNo
18195464GRIPPER FOR ROBOTIC IMAGE GUIDED NEEDLE INSERTIONMay 2023March 2024Allow1100NoNo
18135153Intrasacular Aneurysm Occlusion Device with a Proximal Bowl-Shaped Mesh and a Distal Globular MeshApril 2023May 2024Abandon1341NoNo
18249020SYSTEMS AND METHODS FOR MICROVASCULAR ANASTOMOTIC COUPLER RING DELIVERY DEVICEApril 2023August 2023Allow500YesNo
18123471SKIN CLEANSERMarch 2023October 2025Abandon3140YesNo
18114534MEDICAL DEVICE FOR TREATING ESOPHAGEAL ATRESIAFebruary 2023March 2026Abandon3710NoNo
18113010Neurovascular Flow Diverter and Delivery SystemsFebruary 2023October 2025Allow3211NoNo
18112904Systems and Methods for Customizable Flow Diverter ImplantsFebruary 2023August 2025Allow3010NoNo
18112963Neurovascular Flow Diverter and Delivery SystemsFebruary 2023March 2024Allow1320YesNo
18102414METHODS AND APPARATUS FOR MAGNET-INDUCED COMPRESSION ANASTOMOSIS BETWEEN ADJACENT ORGANSJanuary 2023February 2026Allow3730NoNo
18092985FILAMENTARY DEVICES FOR TREATMENT OF VASCULAR DEFECTSJanuary 2023May 2024Allow1620NoNo
18088368FLEXIBLE STABILIZING MEMBER FOR A CLIP APPLIERDecember 2022June 2025Allow3030YesNo
17994765SYSTEMS AND METHODS FOR MANAGEMENT OF THROMBOSISNovember 2022October 2024Abandon2320NoNo
17999474EMBOLISATION DEVICES AND METHODS OF MANUFACTURING THE SAMENovember 2022September 2024Abandon2120NoNo
17975308SUTURE ANCHOR FOR KNOTLESS FIXATION OF TISSUEOctober 2022June 2023Allow810NoNo
17975321SUTURE ANCHOR FOR KNOTLESS FIXATION OF TISSUEOctober 2022July 2023Allow920NoNo
17970510Intrasacular Aneurysm Occlusion Device with a Proximal-to-Distal Stack of Shape-Changing Embolic StructuresOctober 2022October 2024Abandon2451NoYes
17965502Intrasacular Aneurysm Occlusion Device with Nested StructuresOctober 2022February 2024Abandon1620NoNo
17900798INFUSED NASAL STRIPAugust 2022April 2025Abandon3110NoNo
17889535FIXATION DEVICE CARTRIDGESAugust 2022January 2024Allow1710NoNo
17850247LAPROSCOPIC DEVICES AND METHODS OF USINGJune 2022June 2025Allow3640NoNo
17829313Intrasacular Aneurysm Occlusion Device with Embolic Members Inserted between an Outer Mesh and an Inner MeshMay 2022December 2023Abandon1820NoNo
17827872CLIP APPLIER AND METHODS OF USEMay 2022May 2024Allow2310YesNo
17664619METHOD FOR DELIVERING A SURGICAL HEART VALVEMay 2022May 2025Allow3610NoNo
17748968APPARATUSES FOR ANASTOMOSIS OF TUBULAR VESSELS AND RELATED METHODSMay 2022May 2023Allow1120NoNo
17742927EXPANDING SUTURE ANCHOR HAVING AN ACTUATOR PINMay 2022April 2025Allow3520NoNo
17718828BIOABSORBABLE STAPLE COMPRISING MECHANISMS FOR SLOWING THE ABSORPTION OF THE STAPLEApril 2022December 2025Abandon4421NoNo
17658640SYSTEMS AND METHODS FOR LEFT ATRIAL APPENDAGE CLOSUREApril 2022December 2024Allow3220YesNo
17710619VARIABLE DENIER YARN AND SUTUREMarch 2022November 2022Allow830NoNo
17710780VARIABLE DENIER YARN AND SUTUREMarch 2022October 2023Allow1910NoNo
17702284ANASTOMOSIS ASSIST TOOL AND VASCULAR ANASTOMOSIS METHODMarch 2022June 2023Allow1500NoNo
17761542DISASSEMBLABLE ANASTOMOSIS CLAMPMarch 2022December 2024Allow3310NoNo
17697279ARTERIOTOMY CLOSURE APPARATUS WITH SLOTTED SHOE FOR ADVANTAGEOUS PRESSURE DISTRIBUTIONMarch 2022January 2024Allow2310NoNo
17574364SKIN CLEANSERJanuary 2022March 2023Allow1410NoNo
17425975SURGICAL FORCEPSDecember 2021January 2025Abandon4210NoNo
17623427AN EMBOLIZATION DEVICE FOR PROMOTING CLOT FORMATION IN A BODILY LUMEN AND A METHOD OF ASSEMBLING SAID EMBOLIZATION DEVICEDecember 2021July 2024Abandon3140NoNo
17644202METHOD TO IMPROVE CUTTING PERFOMANCE OF A MALLEABLE BLADEDecember 2021April 2025Allow4031YesNo
17544052SYSTEMS AND METHODS FOR FIXING SOFT TISSUEDecember 2021October 2025Abandon4640NoNo
17536277PARANASAL SINUS MEDICAL DEVICE AND USES THEREOFNovember 2021November 2023Allow2310NoNo
17530031DEVICES, SYSTEMS, AND METHODS FOR A COATED COILNovember 2021July 2023Allow2011YesNo
17516664ADJUSTABLE KNOTLESS LOOPSNovember 2021January 2025Allow3910NoNo
17510950SURGICAL INSTRUMENT WITH LED LIGHTING AND ABSOLUTE ORIENTATIONOctober 2021December 2022Allow1410YesNo
17496719DIFFUSION AND INFUSION RESISTANT IMPLANTABLE DEVICES FOR REDUCING PULSATILE PRESSUREOctober 2021July 2023Allow2210NoNo
17485390Methods of Occluding a Cerebral Aneurysm by Inserting Embolic Members or Material into an Intrasacular ImplantSeptember 2021September 2022Allow1110NoNo
17476845Aneurysm-Occluding Mesh Ribbon with a Series of Loops or Segments Having Distal-to-Proximal Variation in Size, Shape, and/or OrientationSeptember 2021December 2022Allow1510YesNo
17473474SURGICAL INSTRUMENTSeptember 2021July 2025Allow4611NoNo
17473868VARIABLE DENIER YARN AND SUTURESeptember 2021September 2022Allow1221YesNo
17472674Janjua Aneurysm Net with a Stiff Proximal Portion and a Flexible Distal PortionSeptember 2021September 2022Abandon1220NoNo
17467680Intrasacular Aneurysm Occlusion Device with an Embolic-Filled Flexible Mesh Formed from a Radially-Constrained Tubular MeshSeptember 2021August 2022Abandon1120NoNo
17466497INTRASACULAR ANEURYSM OCCLUSION DEVICE WITH GLOBULAR FIRST CONFIGURATION AND BOWL-SHAPED SECOND CONFIGURATIONSeptember 2021April 2022Allow710NoNo
17310404ANASTOMOSIS DEVICEJuly 2021February 2025Allow4320NoNo
17387515PACIFIER DEVICESJuly 2021April 2022Allow911YesNo
17383431Synthetic Perivascular WrapJuly 2021March 2025Allow4420NoNo
17355060SUTURE DELIVERY DEVICEJune 2021July 2024Abandon3720NoNo
17353652Intrasacular Aneurysm Occlusion Device with a Flexible Net or Mesh and Polymer Longitudinal Embolic MembersJune 2021September 2022Abandon1540NoNo
17303922TRANSCATHETER PERCUTANEOUS BALLOON VALVULOTOMYJune 2021November 2023Abandon2910NoNo
17299459COMBINATORIAL THERAPIES INCLUDING IMPLANTABLE DAMPING DEVICES AND THERAPEUTIC AGENTS FOR TREATING A CONDITION AND ASSOCIATED SYSTEMS AND METHODS OF USEJune 2021December 2025Abandon5530NoNo
17331580ADJUSTABLE LOOP WITH LOCKING KNOTMay 2021November 2025Abandon5430YesNo
17302305HEMOSTASIS RELOADABLE CLIPPING DEVICE WITH SLEEVE ENGAGEMENTApril 2021February 2024Allow3300NoNo
17242504METHODS FOR PARTIAL DIVERSION OF THE INTESTINAL TRACTApril 2021April 2024Abandon3510NoNo
17240063Acupressure Headband ApparatusApril 2021May 2024Allow3610NoNo
17228446CRIMPING ACCESSORY DEVICE FOR A PROSTHETIC VALVEApril 2021July 2024Allow3920YesNo
17220002Proximal Concave Neck Bridge with Central Lumen and Distal Net for Occluding Cerebral AneurysmsApril 2021August 2022Allow1740NoYes
17217563DEVICE FOR SUTURE ATTACHMENT FOR MINIMALLY INVASIVE HEART VALVE REPAIRMarch 2021July 2024Allow3910YesNo
17214827Aneurysm Neck Bridge with a Closeable Opening or Lumen Through Which Embolic Material is Inserted into the Aneurysm SacMarch 2021August 2022Allow1740NoNo
17280442VASCULAR ANASTOMOTIC MEMBER COMPRISING SHAPE-MEMORY POLYMERMarch 2021August 2024Allow4110NoNo
17211446Parent Vessel and Intrasacular Devices for Occluding a Cerebral AneurysmMarch 2021September 2022Abandon1840NoNo
17209545SYSTEMS AND METHODS FOR DETERMINING FAILURE OF INTRAGASTRIC DEVICESMarch 2021April 2023Allow2400NoNo
17193042Percutaneous Catheter Directed Intravascular Occlusion DevicesMarch 2021September 2022Allow1940YesNo
17186273METHOD OF POWERING AND COMMUNICATING WITH A STAPLE CARTRIDGEFebruary 2021February 2025Allow4820NoNo
17172473APPARATUSES AND METHODS FOR FIXATION OF ANKLE SYNDESMOSIS OR ACROMIOCLAVICULAR JOINT DISLOCATIONS OF THE SHOULDERFebruary 2021November 2023Abandon3310NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LAUER, CHRISTINA C.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
3
(37.5%)
Examiner Reversed
5
(62.5%)
Reversal Percentile
84.9%
Higher than average

What This Means

With a 62.5% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
26
Allowed After Appeal Filing
14
(53.8%)
Not Allowed After Appeal Filing
12
(46.2%)
Filing Benefit Percentile
85.9%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 53.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner LAUER, CHRISTINA C - Prosecution Strategy Guide

Executive Summary

Examiner LAUER, CHRISTINA C works in Art Unit 3771 and has examined 277 patent applications in our dataset. With an allowance rate of 74.4%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 39 months.

Allowance Patterns

Examiner LAUER, CHRISTINA C's allowance rate of 74.4% places them in the 39% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by LAUER, CHRISTINA C receive 2.68 office actions before reaching final disposition. This places the examiner in the 79% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by LAUER, CHRISTINA C is 39 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +9.7% benefit to allowance rate for applications examined by LAUER, CHRISTINA C. This interview benefit is in the 42% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 20.6% of applications are subsequently allowed. This success rate is in the 23% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 29.2% of cases where such amendments are filed. This entry rate is in the 42% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 114.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 81% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 72.4% of appeals filed. This is in the 60% percentile among all examiners. Of these withdrawals, 47.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 22.2% are granted (fully or in part). This grant rate is in the 11% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 1.1% of allowed cases (in the 68% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 48% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.